関連する実験動画
Updated: Feb 3, 2026

14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
32.5K
重症制御不能喘息における年齢依存的な気道炎症および機能の違い
Jôse Mára de Brito1, Natália de Souza Xavier Costa2, Diogenes Seraphim Ferreira2
1Laboratório de Patologia Ambiental e Experimental, Departamento de Patologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil; Instituto Básico de Biociências, Universidade de Taubaté (UNITAU), Taubaté, SP, Brazil.
The Journal of allergy and clinical immunology
|February 1, 2026
まとめ
重症喘息の小児は成人よりも気道炎症が強く、肺機能は良好であることが示されています。これは、小児重症喘息管理における治療的ウィンドウの可能性を示唆しています。
科学分野:
- 呼吸器学
- 小児喘息研究
- 免疫学
背景:
- 重症喘息の理解は、小児と成人の比較が乏しいことにより限定されている。
- 気管支生検は、気道炎症およびリモデリングに関する洞察を提供する。
研究 の 目的:
- 重症制御不能喘息の小児および成人における組織病理学的および臨床的特徴を比較すること。
- 重症喘息における年齢特異的な違いを特定すること。
主な方法:
- 13人の小児および36人の成人から得られた人口統計学的、臨床的、および検査データの評価。
- 肺機能、呼気一酸化窒素(FeNO)の測定、および気管支生検の実施。
主要な成果:
- 小児は男性の割合が高く、成人では女性の割合が高かった。
- 小児重症喘息患者は、成人(予測FEV1% 55%)と比較して、より良好な肺機能(予測FEV1% 82%)を示した。
- 小児は複数の気道層において、成人よりも有意に高い炎症細胞密度(好酸球、マスト細胞、CD8+ T細胞)を示したが、成人では粘膜下層においてCD4+ T細胞密度が高かった。構造的リモデリングは同様であった。
結論:
- 重症喘息の小児は、成人と比較して、より強い気道炎症を示すものの、肺機能は保たれている。
- 小児および成人重症喘息コホート間では、構造的気道リモデリングは同等であった。
- 本所見は、小児重症喘息における治療的ウィンドウの可能性を示唆しており、年齢に応じた管理戦略が必要であることを示唆している。
関連する概念動画
Inflammation
62.1K
Overview
62.1K
Asthma-I: Introduction
3.5K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.5K
Asthma-III: Symptoms and Complications
3.3K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.3K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Asthma: Pathogenesis and Management
1.3K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.3K
Asthma-II: Pathophysiology and Classification
4.3K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.3K

